American Society of Hematology.
organization
- Reports this week
- 0
- Active events
- 0
- Connections
- 18
What's happening
Earlier this month
-
Lakefront (Q783794) presented research data at the ASH meeting on November 1, 2026, and Aaron Cox is its CFO.Some support1 report
-
Ascentage Pharma Group International presented research data at the ASH Annual Meeting in New Orleans.Some support1 report
-
ADC Therapeutics presented clinical data at the American Society of Hematology meeting.Some support1 report
-
Geron Corporation presented clinical data at the American Society of Hematology meeting.Some support1 report
-
CRISPR Therapeutics presented clinical data at the American Society of Hematology meeting on November 4, 2026.Some support1 report
-
Incyte presented research data at the American Society of Hematology Annual Meeting.Some support4 reports1 development inside
-
CRH presented trial results for Cantargia at the American Society of Hematology meeting.Some support2 reports
-
An ASH study indicates that iron deficiency is prevalent among US adults.Some support2 reports
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around American Society of Hematology this week
News at the entities that move American Society of Hematology most-
FDA StructuralPresident Boakai is addressed by community petitions, and Rudolph Merab is named as the Managing Director of the FDA.Moves American Society of Hematology
-
Eli Lilly and Company Shared contextEli Lilly is building a new manufacturing facility in Lehigh Valley, Pennsylvania, while Cisco reports on its market performance.Moves American Society of Hematology
-
company Shared contextA company developing in Québec, Canada, is facing issues regarding its compliance with New York Stock Exchange listing rules.Moves American Society of Hematology
Connections
The 12 strongest of 18, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Robert S. Negrin Structural
Robert S. Negrin serves as the president of the American Society of Hematology.
-
FDA Structural
FDA clearance is a prerequisite for presenting research at the American Society of Hematology.
-
ADC Therapeutics Operational
ADC Therapeutics presented data at a meeting organized by the American Society of Hematology.
-
Scripps Research Mentioned together
Scripps Research presents scientific findings at meetings organized by the American Society of Hematology.
-
CRISPR Therapeutics Operational
CRISPR Therapeutics actively presents clinical data at the American Society of Hematology meeting.
-
American College of Rheumatology Mentioned together
Both entities are identified as professional medical organizations.
-
Eli Lilly and Company Shared context
Lilly leveraged the American Society of Hematology meeting as a platform to present clinical data.
-
Incyte Mentioned together
Incyte presents scientific data at the American Society of Hematology Annual Meeting.
Show all 12 connections
-
Geron Corporation Shared context
Geron Corporation presents scientific data at the American Society of Hematology meeting.
-
company Shared context
The company presents its research findings at the American Society of Hematology meeting.
-
CRH Mentioned together
No direct evidence linking CRH and American Society of Hematology was found in the provided timeline.
-
University of Minnesota Mentioned together
No evidence found linking the two entities.
History
Events by the month they beganNovember 2026
7 events- Lakefront (Q783794) presented research data at the ASH meeting on November 1, 2026, and Aaron Cox is its CFO.
- Ascentage Pharma Group International presented research data at the ASH Annual Meeting in New Orleans.
- ADC Therapeutics presented clinical data at the American Society of Hematology meeting.
- Geron Corporation presented clinical data at the American Society of Hematology meeting.
- CRISPR Therapeutics presented clinical data at the American Society of Hematology meeting on November 4, 2026.
- Incyte presented research data at the American Society of Hematology Annual Meeting.
- CRH presented trial results for Cantargia at the American Society of Hematology meeting.